Literature DB >> 26139430

Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia.

P Ruminy1, V Marchand1, N Buchbinder2, T Larson1, B Joly1, D Penther1, E Lemasle3, S Lepretre1,3, E Angot4, S Mareschal1, P-J Viailly1, S Dubois1, F Clatot5, M Viennot1, E Bohers1, D Rizzo1, M Cornic6, P Bertrand1, C Girod2, V Camus3, P Etancelin1, G Buchonnet7, P Schneider2, J-M Picquenot1,6, J-P Vannier2, C Bastard1, H Tilly1,3, F Jardin1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26139430     DOI： 10.1038/leu.2015.177

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.

Authors:  C Graux; J Cools; C Melotte; H Quentmeier; A Ferrando; R Levine; J R Vermeesch; M Stul; B Dutta; N Boeckx; A Bosly; P Heimann; A Uyttebroeck; N Mentens; R Somers; R A F MacLeod; H G Drexler; A T Look; D G Gilliland; L Michaux; P Vandenberghe; I Wlodarska; Peter Marynen; Anne Hagemeijer
Journal:  Nat Genet       Date:  2004-09-12       Impact factor: 38.330

Review 2.  Genomics in acute lymphoblastic leukaemia: insights and treatment implications.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Nat Rev Clin Oncol       Date:  2015-03-17       Impact factor: 66.675

3.  A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia.

Authors:  R J Jaju; C Fidler; O A Haas; A J Strickson; F Watkins; K Clark; N C Cross; J F Cheng; P D Aplan; L Kearney; J Boultwood; J S Wainscoat
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

Review 4.  Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

Authors:  J J van Dongen; E A Macintyre; J A Gabert; E Delabesse; V Rossi; G Saglio; E Gottardi; A Rambaldi; G Dotti; F Griesinger; A Parreira; P Gameiro; M G Diáz; M Malec; A W Langerak; J F San Miguel; A Biondi
Journal:  Leukemia       Date:  1999-12       Impact factor: 11.528

5.  The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.

Authors:  M von Lindern; M Fornerod; S van Baal; M Jaegle; T de Wit; A Buijs; G Grosveld
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

6.  The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family.

Authors:  M H Dreyling; J A Martinez-Climent; M Zheng; J Mao; J D Rowley; S K Bohlander
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; J Racquel Collins-Underwood; Letha A A Phillips; Michael G Loudin; Wei Liu; Jinghui Zhang; Jing Ma; Elaine Coustan-Smith; Richard C Harvey; Cheryl L Willman; Fady M Mikhail; Julia Meyer; Andrew J Carroll; Richard T Williams; Jinjun Cheng; Nyla A Heerema; Giuseppe Basso; Andrea Pession; Ching-Hon Pui; Susana C Raimondi; Stephen P Hunger; James R Downing; William L Carroll; Karen R Rabin
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

Review 8.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

9.  The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.

Authors:  J Borrow; V P Stanton; J M Andresen; R Becher; F G Behm; R S Chaganti; C I Civin; C Disteche; I Dubé; A M Frischauf; D Horsman; F Mitelman; S Volinia; A E Watmore; D E Housman
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

10.  The MLL recombinome of acute leukemias in 2013.

Authors:  C Meyer; J Hofmann; T Burmeister; D Gröger; T S Park; M Emerenciano; M Pombo de Oliveira; A Renneville; P Villarese; E Macintyre; H Cavé; E Clappier; K Mass-Malo; J Zuna; J Trka; E De Braekeleer; M De Braekeleer; S H Oh; G Tsaur; L Fechina; V H J van der Velden; J J M van Dongen; E Delabesse; R Binato; M L M Silva; A Kustanovich; O Aleinikova; M H Harris; T Lund-Aho; V Juvonen; O Heidenreich; J Vormoor; W W L Choi; M Jarosova; A Kolenova; C Bueno; P Menendez; S Wehner; C Eckert; P Talmant; S Tondeur; E Lippert; E Launay; C Henry; P Ballerini; H Lapillone; M B Callanan; J M Cayuela; C Herbaux; G Cazzaniga; P M Kakadiya; S Bohlander; M Ahlmann; J R Choi; P Gameiro; D S Lee; J Krauter; P Cornillet-Lefebvre; G Te Kronnie; B W Schäfer; S Kubetzko; C N Alonso; U zur Stadt; R Sutton; N C Venn; S Izraeli; L Trakhtenbrot; H O Madsen; P Archer; J Hancock; N Cerveira; M R Teixeira; L Lo Nigro; A Möricke; M Stanulla; M Schrappe; L Sedék; T Szczepański; C M Zwaan; E A Coenen; M M van den Heuvel-Eibrink; S Strehl; M Dworzak; R Panzer-Grümayer; T Dingermann; T Klingebiel; R Marschalek
Journal:  Leukemia       Date:  2013-04-30       Impact factor: 11.528
View more
  11 in total

1.  NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.

Authors:  Nicolas Duployez; Guillaume Grzych; Benoît Ducourneau; Martin Alarcon Fuentes; Nathalie Grardel; Thomas Boyer; Wadih Abou Chahla; Bénédicte Bruno; Brigitte Nelken; Emmanuelle Clappier; Claude Preudhomme
Journal:  Haematologica       Date:  2015-12-17       Impact factor: 9.941

2.  Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma.

Authors:  Nicolas Piton; Philippe Ruminy; Claire Gravet; Vinciane Marchand; Élodie Colasse; Aude Lamy; Cécile Le Naoures Mear; Fréderic Bibeau; Florent Marguet; Florian Guisier; Mathieu Salaün; Luc Thiberville; Fabrice Jardin; Jean-Christophe Sabourin
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

3.  An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology.

Authors:  Nicolas Piton; Marie-Delphine Lanic; Florent Marguet; Aude Lamy; France Blanchard; Florian Guisier; Mathieu Viennot; Mathieu Salaün; Luc Thiberville; Fabrice Jardin; Jean-Christophe Sabourin; Philippe Ruminy
Journal:  Lab Invest       Date:  2021-01-25       Impact factor: 5.662

4.  Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML.

Authors:  Sylvain Mareschal; Anna Palau; Johan Lindberg; Philippe Ruminy; Christer Nilsson; Sofia Bengtzén; Marie Engvall; Anna Eriksson; Anne Neddermeyer; Vinciane Marchand; Monika Jansson; My Björklund; Fabrice Jardin; Mattias Rantalainen; Andreas Lennartsson; Lucia Cavelier; Henrik Grönberg; Sören Lehmann
Journal:  Blood Adv       Date:  2021-02-23

5.  Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.

Authors:  Marie-Delphine Lanic; François Le Loarer; Vinciane Rainville; Vincent Sater; Mathieu Viennot; Ludivine Beaussire; Pierre-Julien Viailly; Emilie Angot; Isabelle Hostein; Fabrice Jardin; Philippe Ruminy; Marick Laé
Journal:  Mod Pathol       Date:  2022-01-24       Impact factor: 7.842

6.  Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML.

Authors:  Raphael Itzykson; Thomas Cluzeau; Matthieu Duchmann; Orianne Wagner-Ballon; Thomas Boyer; Meyling Cheok; Elise Fournier; Estelle Guerin; Laurène Fenwarth; Bouchra Badaoui; Nicolas Freynet; Emmanuel Benayoun; Daniel Lusina; Isabel Garcia; Claude Gardin; Pierre Fenaux; Cécile Pautas; Bruno Quesnel; Pascal Turlure; Christine Terré; Xavier Thomas; Juliette Lambert; Aline Renneville; Claude Preudhomme; Hervé Dombret
Journal:  Leukemia       Date:  2021-10-06       Impact factor: 11.528

7.  Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.

Authors:  Marie Passet; Rathana Kim; Stéphanie Gachet; François Sigaux; Julie Chaumeil; Ava Galland; Thomas Sexton; Samuel Quentin; Lucie Hernandez; Lise Larcher; Hugo Bergugnat; Tao Ye; Nezih Karasu; Aurélie Caye; Beate Heizmann; Isabelle Duluc; Patrice Chevallier; Philippe Rousselot; Françoise Huguet; Thibaut Leguay; Mathilde Hunault; Françoise Pflumio; Jean-Noël Freund; Camille Lobry; Véronique Lhéritier; Hervé Dombret; Claire Domon-Dell; Jean Soulier; Nicolas Boissel; Emmanuelle Clappier
Journal:  Blood       Date:  2022-06-16       Impact factor: 25.476

8.  Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group.

Authors:  Alice Marceau-Renaut; Nicolas Duployez; Benoît Ducourneau; Myriam Labopin; Arnaud Petit; Alexandra Rousseau; Sandrine Geffroy; Maxime Bucci; Wendy Cuccuini; Odile Fenneteau; Philippe Ruminy; Brigitte Nelken; Stéphane Ducassou; Virginie Gandemer; Thierry Leblanc; Gérard Michel; Yves Bertrand; André Baruchel; Guy Leverger; Claude Preudhomme; Hélène Lapillonne
Journal:  Hemasphere       Date:  2018-02-21

9.  Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion.

Authors:  Gauthier Decool; Carine Domenech; Nathalie Grardel; Adriana Plesa; Imelda Raczkiewicz; Benoit Ducourneau; Philippe Ruminy; Marie-Pierre Pages; Sandrine Girard; Laurène Fenwarth; Claude Preudhomme; Yves Bertrand; Nicolas Duployez
Journal:  Hemasphere       Date:  2019-06-04

10.  Co-occurrence of PML-RARA gene fusion, chromosome 8 trisomy, and FLT3 ITD mutation in a young female patient with de novo acute myeloid leukemia and early death: A CARE case report.

Authors:  Florin Tripon; George Andrei Crauciuc; Alina Bogliş; Valeriu Moldovan; Johanna Sándor-Kéri; István Jr Benedek; Adrian Pavel Trifa; Claudia Bănescu
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.